HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs
SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses...
Source: globenewswire.com
Stay updated with breaking news from Mab Class Action. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses...